» Articles » PMID: 36195553

Exploring the Potential of Multinuclear Solid-State H, C, and Cl Magnetic Resonance To Characterize Static and Dynamic Disorder in Pharmaceutical Hydrochlorides

Overview
Journal Chemphyschem
Specialty Chemistry
Date 2022 Oct 4
PMID 36195553
Authors
Affiliations
Soon will be listed here.
Abstract

Crystallographic disorder, whether static or dynamic, can be detrimental to the physical and chemical stability, ease of crystallization and dissolution rate of an active pharmaceutical ingredient. Disorder can result in a loss of manufacturing control leading to batch-to-batch variability and can lengthen the process of structural characterization. The range of NMR active nuclei makes solid-state NMR a unique technique for gaining nucleus-specific information about crystallographic disorder. Here, we explore the use of high-field Cl solid-state NMR at 23.5 T to characterize both static and dynamic crystallographic disorder: specifically, dynamic disorder occurring in duloxetine hydrochloride (1), static disorder in promethazine hydrochloride (2), and trifluoperazine dihydrochloride (3). In all structures, the presence of crystallographic disorder was confirmed by C cross-polarization magic-angle spinning (CPMAS) NMR and supported by GIPAW-DFT calculations, and in the case of 3, H solid-state NMR provided additional confirmation. Applying Cl solid-state NMR to these compounds, we show that higher magnetic fields are beneficial for resolving the crystallographic disorder in 1 and 3, while broad spectral features were observed in 2 even at higher fields. Combining the data obtained from H, C, and Cl NMR, we show that 3 exhibits a unique case of disorder involving the N-H hydrogen positions of the piperazinium ring, driving the chloride anions to occupy three distinct sites.

Citing Articles

An unusual ionic cocrystal of ponatinib hydrochloride: characterization by single-crystal X-ray diffraction and ultra-high field NMR spectroscopy.

Stirk A, Holmes S, Souza F, Hung I, Gan Z, Britten J CrystEngComm. 2024; 26(9):1219-1233.

PMID: 38419975 PMC: 10897533. DOI: 10.1039/d3ce01062g.


Exploring the Potential of Multinuclear Solid-State H, C, and Cl Magnetic Resonance To Characterize Static and Dynamic Disorder in Pharmaceutical Hydrochlorides.

Szell P, Rehman Z, Tatman B, Hughes L, Blade H, Brown S Chemphyschem. 2022; 24(3):e202200558.

PMID: 36195553 PMC: 10099218. DOI: 10.1002/cphc.202200558.

References
1.
Harris R . Applications of solid-state NMR to pharmaceutical polymorphism and related matters. J Pharm Pharmacol. 2007; 59(2):225-39. DOI: 10.1211/jpp.59.2.0009. View

2.
Vogt F, Williams G, Strohmeier M, Johnson M, Copley R . Solid-state NMR analysis of a complex crystalline phase of ronacaleret hydrochloride. J Phys Chem B. 2014; 118(34):10266-84. DOI: 10.1021/jp505061j. View

3.
Hamaed H, Pawlowski J, Cooper B, Fu R, Eichhorn S, Schurko R . Application of solid-state 35Cl NMR to the structural characterization of hydrochloride pharmaceuticals and their polymorphs. J Am Chem Soc. 2008; 130(33):11056-65. DOI: 10.1021/ja802486q. View

4.
Webber A, Emsley L, Claramunt R, Brown S . NMR crystallography of campho[2,3-c]pyrazole (Z' = 6): combining high-resolution 1H-13C solid-state MAS NMR spectroscopy and GIPAW chemical-shift calculations. J Phys Chem A. 2010; 114(38):10435-42. DOI: 10.1021/jp104901j. View

5.
Hirsh D, Su Y, Nie H, Xu W, Stueber D, Variankaval N . Quantifying Disproportionation in Pharmaceutical Formulations with Cl Solid-State NMR. Mol Pharm. 2018; 15(9):4038-4048. DOI: 10.1021/acs.molpharmaceut.8b00470. View